Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells. - Christo, Susan N; McDonald, Keely M; Burn, Thomas N; Kurd, Nadia; Stanfield, Jessica; Kaneda, Megan M; Seelige, Ruth; Dillon, Christopher P; Fisher, Timothy S; Baaten, Bas; Mackay, Laura K (Clinical & Translational Immunology, 2024)